MN
Manuel Navas Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Financials
Ratings Past Year
39
Avg Return
Past Year
Past Year
3.8%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
52.8%
Neutral
47.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Banks - Diversified
Banks - Regional
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Assumed
| $66 |
7%
upside
| 1 | +1.2% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Overweight
Assumed
| $107 |
8%
upside
| 1 | +2.4% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Overweight
Assumed
| $82 |
6%
upside
| 1 | +0.9% |
0
%
| 12 Mar ‘26 1 month ago |
|
|
|
Overweight
Reiterated
| $22 |
7%
upside
| 2 | +9.5% |
0
%
| 3 Feb ‘26 2 months ago |
|
|
|
Neutral
Reiterated
| $36 |
2%
upside
| 2 | – |
–
| 2 Feb ‘26 2 months ago |
|
|
|
Neutral
Reiterated
| $24 |
3%
upside
| 2 | – |
–
| 30 Jan ‘26 2 months ago |
|
|
|
Neutral
Maintained
| $67 |
5%
downside
| 3 | +1.6% |
0
%
| 29 Jan ‘26 2 months ago |
|
|
|
Neutral
Maintained
| $130 |
2%
upside
| 3 | – |
–
| 23 Jan ‘26 2 months ago |
|
|
|
Overweight
Reiterated
| $21 |
17%
upside
| 4 | +8% |
0
%
| 22 Jan ‘26 2 months ago |
|
|
|
Neutral
Assumed
| $45 |
6%
upside
| 1 | – |
–
| 15 Jan ‘26 3 months ago |
|
|
|
Overweight
Assumed
| $152 |
3%
upside
| 1 | +4.6% |
0
%
| 15 Jan ‘26 3 months ago |
|
|
|
Overweight
Assumed
| $42 |
16%
upside
| 1 | -3% |
0
%
| 17 Dec ‘25 4 months ago |
|
|
|
Neutral
Assumed
| $13 |
3%
downside
| 1 | – |
–
| 17 Dec ‘25 4 months ago |
|
|
|
Overweight
Assumed
| $21 |
12%
upside
| 1 | -1.3% |
0
%
| 17 Dec ‘25 4 months ago |
|
|
|
Neutral
Assumed
| $34 |
10%
downside
| 1 | – |
–
| 3 Dec ‘25 4 months ago |
|
|
|
Neutral
Assumed
| $74 |
14%
downside
| 1 | – |
–
| 3 Dec ‘25 4 months ago |
|
|
|
Neutral
Assumed
| $62 |
2%
downside
| 1 | – |
–
| 3 Dec ‘25 4 months ago |
|
|
|
Buy
Maintained
| $55 |
20%
upside
| 2 | -0.79% |
0
%
| 31 Jul ‘25 8 months ago |
|
|
|
Buy
Maintained
| $40 |
2%
upside
| 1 | -1.9% |
0
%
| 30 Jul ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $67 |
10%
downside
| 1 | – |
–
| 29 Jul ‘25 8 months ago |
|
|
|
Buy
Maintained
| $73 |
10%
upside
| 1 | -0.13% |
0
%
| 28 Jul ‘25 8 months ago |
|
|
|
Buy
Maintained
| $45 |
2%
downside
| 1 | +9.8% |
0
%
| 28 Jul ‘25 8 months ago |
|
|
|
Buy
Maintained
| $24 |
5%
upside
| 1 | +8.1% |
0
%
| 28 Jul ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $32 |
8%
downside
| 1 | – |
–
| 24 Jul ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $20 |
9%
downside
| 3 | – |
–
| 17 Jul ‘25 9 months ago |
|